Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as a research subject, Myriad Genetics feels it is entitled to its patent on the new DNA compound, but petitioners in a Supreme Court case are contesting it on the grounds that a company cannot copyright nature.
Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate it as a research subject, Myriad Genetics now feels it is entitled to its patent on the new DNA compound
A. Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as a research subject, Myriad Genetics feels it is entitled to its patent on the new DNA compound --- to isolate them (both genes) can go with only the plural research subjects – Therefore, wrong
B. Having had extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as research subjects, Myriad Genetics now feels it is entitled to its patent on the new DNA compound –---having had extracted is awful.
C. Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate it as a research subject, Myriad Genetics now feels it is entitled to its patent on the new DNA compound – ----isolate it and a research subject go in tandem. It refers to the new BRCA-free DNA compound; may be the best choice.
D. Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as research subjects, Myriad Genetics now feels it is entitled to its patents on the new DNA compounds – The main clause is a problem, there is only one new DNA compound, not compounds as has been made out in the choice
E. Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as research subjects, Myriad Genetics now feels entitled to its patents on the new DNA compound ---- One can have only one patent for one research subject i.e. the new DNA compound. The plural ‘its patents’ is wrong.